COVID-19 Might Increase Risk for Neurodegenerative Disease

People who had COVID-19 might have an increased risk for developing neurodegenerative diseases, such as Parkinson’s disease, researchers in Australia found. Moreover, the researchers have offered a possible treatment to reduce the  COVID-induced neuroinflammation. COVID-19 activates an inflammatory response in the brain that is similar to Parkinson’s disease, contributing…

Focused Ultrasound in Parkinson’s: A Conversation With Arjun Desai, MD

Last November, the U.S. Food and Drug Administration approved Exablate Neuro to treat motor symptoms in Parkinson’s disease patients, as reported by Parkinson’s News Today‘s Patricia Inacio, PhD. Created by medical device company Insightec, Exablate Neuro is a magnetic resonance, image-guided, focused ultrasound (MRgFUS) system that can treat tremors…

UK Surveys Capture How Pandemic Affected Patients, Caregivers

Based on survey results indicating that pandemic restrictions considerably aggravated Parkinson’s disease (PD) symptoms and hampered care, Parkinson’s UK is calling on its various governments to take remedial steps to improve both care and access. Calls for action derive from a 41-page report by the nonprofit organization and Lancaster…